| Literature DB >> 8843494 |
Y Barak1, J Levine, A Glasman, A Elizur, R H Belmaker.
Abstract
1. A double-blind controlled crossover trial of 6 gm of inositol daily vs glucose for one month each was carried out in 11 Alzheimer patients. 2. Overall CAMCOG scores showed a trend for greater improvement with inositol that was not significant. 3. Language and orientation improved significantly more on inositol than on placebo. There were no serious side effects. 4. Higher doses of inositol should be studied in Alzheimer's Disease for longer periods.Entities:
Mesh：
Substances：
Year: 1996 PMID： 8843494 DOI： 10.1016/0278-5846(96)00043-7
Source DB: PubMed Journal: Prog Neuropsychopharmacol Biol Psychiatry ISSN： 0278-5846 Impact factor: 5.067